Notice NOT-GM-17-019 from the NIH Guide for Grants and Contracts

Notice NOT-CA-17-078 from the NIH Guide for Grants and Contracts

Notice NOT-OD-17-106 from the NIH Guide for Grants and Contracts

Notice NOT-AG-17-015 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-18-500 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, is one of several FOAs aimed at supporting transformative discoveries that will lead to breakthroughs in understanding human brain function. Guided by the long-term scientific plan, BRAIN 2025: A Scientific Vision, this FOA specifically seeks to support efforts addressing core ethical issues associated with research focused on the human brain and resulting from emerging technologies and advancements supported by the BRAIN Initiative. The hope is that efforts supported under this FOA might be both complementary and integrative with the transformative, breakthrough neuroscience discoveries supported through the BRAIN Initiative.

Notice NOT-DE-17-013 from the NIH Guide for Grants and Contracts

Notice NOT-MH-17-046 from the NIH Guide for Grants and Contracts

Notice NOT-MH-17-047 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MD-17-006 from the NIH Guide for Grants and Contracts. The purpose of the Research Centers in Minority Institutions (RCMI) Program is to expand the national capacity for research in the health sciences by providing cooperative agreement support to institutions that offer doctorate degrees in the health professions or in a health-related science and have a historical and current commitment to educating underrepresented students, and for institutions that deliver health care services, providing clinical services to medically underserved communities. The primary goals of the RCMI specialized centers are to: (1) enhance institutional research capacity within the areas of basic biomedical, behavioral, and/or clinical research; (2) enable all levels of investigators to become more successful in obtaining competitive extramural support, especially from NIH, particularly on diseases that disproportionately impact minority and other health disparity populations; (3) foster environments conducive to career enhancement with a special emphasis on development of new and early career investigators; (4) enhance the quality of all scientific inquiry and promote research on minority health and health disparities; and (5) establish sustainable relationships with community-based organizations that will partner with the RCMI Institution.

Funding Opportunity PAR-17-471 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support bi-phasic developmental, discovery-driven, or hypothesis-driven research focused on innovative strategies to detect HIV either within the first two weeks of infection or to monitor viral rebound after stopping or developing resistance to antiretroviral therapy. Applications should propose simple diagnostic tools that would be feasible for a self-testing platform to allow untrained individuals to detect HIV. Interdisciplinary collaborations that include biomedical, physical, and behavioral sciences are highly encouraged.

Funding Opportunity PAR-17-470 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support US-Caribbean collaborative research to develop or extend cohort or surveillance studies on chronic disease in the Caribbean region that are aligned with existing publicly available US datasets. The intent is for these cohorts or datasets to be used for ongoing comparative research to better understand the health of Caribbean immigrant populations in the US.

Notice NOT-DA-17-054 from the NIH Guide for Grants and Contracts

Notice NOT-DK-17-018 from the NIH Guide for Grants and Contracts

Notice NOT-GM-17-020 from the NIH Guide for Grants and Contracts

Notice NOT-HG-17-016 from the NIH Guide for Grants and Contracts

Notice NOT-NS-18-007 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AA-18-006 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought to conduct basic and pre-clinical studies addressing high impact areas in Alcoholic Hepatitis under the UH2/UH3 Phase Innovation Awards Cooperative Agreement funding mechanism.

Funding Opportunity RFA-AA-18-005 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought to conduct investigator-initiated single-center feasibility and pilot studies aimed to optimize critical elements for full-scale clinical trial in patients with AH under the U01 Research Project Cooperative Agreements funding mechanism.

Funding Opportunity RFA-AA-18-004 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought for a Data Coordinating Center (DCC) to provide expert assistance to support the AH Network on data management, statistical analysis, biospecimen collection, and logistical support under the U24 Resource-Related Research Projects Cooperative Agreements funding mechanism.

Funding Opportunity RFA-AA-18-003 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought to conduct translational studies aimed on improving various aspects of AH diagnosis and intervention under the U01 Cooperative Agreements funding mechanism.